Statistical methods in endocrinology & metabolism trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
ANCOVA
Multiple imputation / missing data
Non-inferiority trial design
Logistic regression
Odds ratio
Mixed-effects model
MMRM (mixed model for repeated measures)
Cochran-Mantel-Haenszel test
All endocrinology & metabolism trials
1,009 results
- MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID: Complete Statistical AnalysisIndependent statistical analysis of MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00794508).
- Mobile Attention Retraining in Overweight Female Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Mobile Attention Retraining in Overweight Female Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02977403).
- Mobile Health Intervention to Identify Early Responders to Treatment in Adolescent Obesity: Complete Statistical AnalysisIndependent statistical analysis of Mobile Health Intervention to Identify Early Responders to Treatment in Adolescent Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Modulation of Human Myocardial Metabolism by GLP-1 Dose Response: Complete Statistical AnalysisIndependent statistical analysis of Modulation of Human Myocardial Metabolism by GLP-1 Dose Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01607450).
- Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin: Complete Statistical AnalysisIndependent statistical analysis of Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MOVe-OUTIndependent statistical analysis of the MOVe-OUT randomized trial, including its design, weight-change endpoint, t-test methodology, missing-data approach, reported estimates, confidence intervals, p-values, safety, and statistical interpretation.
- MOVE!+UP: Testing a Tailored Weight Management Program for Veterans With PTSD: Complete Statistical AnalysisIndependent statistical analysis of MOVE!+UP: Testing a Tailored Weight Management Program for Veterans With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MUCINIndependent statistical analysis of Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MUFAPUFAIndependent statistical analysis of Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Multi-level Supermarket Discount Study: Complete Statistical AnalysisIndependent statistical analysis of Multi-level Supermarket Discount Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04178824).
- Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant: Complete Statistical AnalysisIndependent statistical analysis of Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Multiple Ascending Dose Study of AMG 598 in Adults With Obesity: Complete Statistical AnalysisIndependent statistical analysis of Multiple Ascending Dose Study of AMG 598 in Adults With Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698: Complete Statistical AnalysisIndependent statistical analysis of Multiple Treatment Session Study to Assess GSK2398852 Administered Following and Along With GSK2315698: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Musculoskeletal Effects of Bicarbonate: Complete Statistical AnalysisIndependent statistical analysis of Musculoskeletal Effects of Bicarbonate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01475214).
- MYCureIndependent statistical analysis of Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Mylan Insulin Aspart Study: Complete Statistical AnalysisIndependent statistical analysis of Mylan Insulin Aspart Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03760068).
- N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC): Complete Statistical AnalysisIndependent statistical analysis of N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03759639).
- N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure: Complete Statistical AnalysisIndependent statistical analysis of N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00248625).
- Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA: Complete Statistical AnalysisIndependent statistical analysis of Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01893801).
- NAD+ Precursor Supplementation in Friedreich’s Ataxia: Complete Statistical AnalysisIndependent statistical analysis of NAD+ Precursor Supplementation in Friedreich's Ataxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04817111).
- NAFLDIndependent statistical analysis of Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Navigator II Continuous Glucose Monitor Home Use Study: Complete Statistical AnalysisIndependent statistical analysis of Navigator II Continuous Glucose Monitor Home Use Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01455064).
- NB-001 in Children and Adolescents With 22q11 Deletion Syndrome: Complete Statistical AnalysisIndependent statistical analysis of NB-001 in Children and Adolescents With 22q11 Deletion Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05290493).
- NCGENES2Independent statistical analysis of North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03548779).
- Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy: Complete Statistical AnalysisIndependent statistical analysis of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Neoadjuvant Immunotherapy in Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Immunotherapy in Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04434560).
- Neurological Impacts of Artificial Sweeteners in the Context of Diet Sodas: Complete Statistical AnalysisIndependent statistical analysis of Neurological Impacts of Artificial Sweeteners in the Context of Diet Sodas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neuropathic Pain Syndrome Patient Study (MK-0000-072): Complete Statistical AnalysisIndependent statistical analysis of Neuropathic Pain Syndrome Patient Study (MK-0000-072): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00570310).
- New Onset Type 1 Diabetes: Role of Exenatide: Complete Statistical AnalysisIndependent statistical analysis of New Onset Type 1 Diabetes: Role of Exenatide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01269034).
- New Ways to Help Patients Improve Their Diabetes Control: Complete Statistical AnalysisIndependent statistical analysis of New Ways to Help Patients Improve Their Diabetes Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01143870).
- NICE-SUGARA detailed statistical analysis of the NICE-SUGAR randomized phase 4 trial evaluating intensive insulin therapy versus conventional insulin therapy in critically ill patients with hyperglycemia.
- NIRAFIndependent statistical analysis of Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Niraparib + Dostarlimab + RT in Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Niraparib + Dostarlimab + RT in Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04409002).
- Nitrite Infusion in Islet Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Nitrite Infusion in Islet Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03544242).
- Nitroglycerin Infusion During Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nitroglycerin Infusion During Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01901419).
- OASIS Wound Matrix (Oasis) Mechanism of Action: Complete Statistical AnalysisIndependent statistical analysis of OASIS Wound Matrix (Oasis) Mechanism of Action: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00570141).
- Obesity and Nonalcoholic Fatty Liver Disease: Complete Statistical AnalysisIndependent statistical analysis of Obesity and Nonalcoholic Fatty Liver Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00262964).
- Obesity, Sleep Apnea, and Insulin Resistance: Complete Statistical AnalysisIndependent statistical analysis of Obesity, Sleep Apnea, and Insulin Resistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02192684).
- Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure: Complete Statistical AnalysisIndependent statistical analysis of Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OCEANIndependent statistical analysis of Randomized Study of Obicetrapib in Combination With Ezetimibe: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04770389).
- OLEIndependent statistical analysis of Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- OLE-IEDATIndependent statistical analysis of Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- OLOLIndependent statistical analysis of Our Lifestyles Our Lives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02965729).
- Omarigliptin (MK-3102) Clinical Trial – Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015): Complete Statistical AnalysisIndependent statistical analysis of Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015): primary endpoint results, effect estimate with confidence interval,…
- Omentectomy and Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Omentectomy and Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00923260).
- ON TARGET DMIndependent statistical analysis of Comparison of Type 2 Diabetes Pharmacotherapy Regimens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05073692).
- One Touch VerioIQ US Clinical Outcomes Study: Complete Statistical AnalysisIndependent statistical analysis of One Touch VerioIQ US Clinical Outcomes Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01627899).
- One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study: Complete Statistical AnalysisIndependent statistical analysis of One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580788).